Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Global Cord Blood Corporation
Hong Kong, Hong Kong
- Ownership
- Private
- Employees
- ~1202
- Development stage
- Other
01
Overview
Global Cord Blood Corporation is the world’s largest cord blood banking network by inventory, owning and operating exclusive license banks in multiple Chinese provinces; however, the corporate entity is in provisional liquidation and its stock is delisted, while operations in China appear ongoing at subsidiary level
- Therapeutic areas
- HematologyOther
- Modalities
- Stem cell therapy (umbilical cord blood stem cells)
- Industry
- Non-Drug Biotech
02
Partnerships
10% equity stake in Cordlife Groupattempted Cellenkos acquisition
Beyond the preview
Go deeper on Global Cord Blood Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Global Cord Blood Corporation.